Cargando…

Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway

TGF β-activated kinase 1 (TAK1) is an important participant in inflammatory pathogenesis for diseases such as rheumatoid arthritis (RA) and gouty arthritis. The central position it occupies between the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) pathways makes it an at...

Descripción completa

Detalles Bibliográficos
Autores principales: Panipinto, Paul M., Singh, Anil K., Shaikh, Farheen S., Siegel, Ruby J., Chourasia, Mukesh, Ahmed, Salahuddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621335/
https://www.ncbi.nlm.nih.gov/pubmed/34830460
http://dx.doi.org/10.3390/ijms222212580
_version_ 1784605433056460800
author Panipinto, Paul M.
Singh, Anil K.
Shaikh, Farheen S.
Siegel, Ruby J.
Chourasia, Mukesh
Ahmed, Salahuddin
author_facet Panipinto, Paul M.
Singh, Anil K.
Shaikh, Farheen S.
Siegel, Ruby J.
Chourasia, Mukesh
Ahmed, Salahuddin
author_sort Panipinto, Paul M.
collection PubMed
description TGF β-activated kinase 1 (TAK1) is an important participant in inflammatory pathogenesis for diseases such as rheumatoid arthritis (RA) and gouty arthritis. The central position it occupies between the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) pathways makes it an attractive therapeutic target. As this field has developed in recent years, several novel inhibitors have been presented as having specific activity that reduces the TAK1 function either covalently as in the case of 5Z-7-oxozeanol (5Z7O) or reversibly (NG-25). However, the mechanism through which takinib elicits its anti-inflammatory activity remains elusive. While this inhibitor shows great promise, a thorough analysis of its inhibitor function and its potential off-target effects is necessary before addressing its clinical potential or its use in inflammatory conditions. An analysis through Western blot showed an unexpected increase in IL-1β-induced TAK1 phosphorylation—a prerequisite for and indicator of its functional potential—by takinib while simultaneously demonstrating the inhibition of the JAK/STAT pathway in human rheumatoid arthritis synovial fibroblasts (RASFs) in vitro. In THP-1 monocyte-derived macrophages, takinib again led to the lipopolysaccharide-induced phosphorylation of TAK1 without a marked inhibition of the TAK1 downstream effectors, namely, of c-Jun N-terminal kinase (JNK), phospho-c-Jun, NF-κB phospho-p65 or phospho-IκBα. Taken together, these findings indicate that takinib inhibits inflammation in these cells by targeting multiple signaling pathways, most notably the JAK/STAT pathway in human RASFs.
format Online
Article
Text
id pubmed-8621335
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86213352021-11-27 Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway Panipinto, Paul M. Singh, Anil K. Shaikh, Farheen S. Siegel, Ruby J. Chourasia, Mukesh Ahmed, Salahuddin Int J Mol Sci Article TGF β-activated kinase 1 (TAK1) is an important participant in inflammatory pathogenesis for diseases such as rheumatoid arthritis (RA) and gouty arthritis. The central position it occupies between the mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) pathways makes it an attractive therapeutic target. As this field has developed in recent years, several novel inhibitors have been presented as having specific activity that reduces the TAK1 function either covalently as in the case of 5Z-7-oxozeanol (5Z7O) or reversibly (NG-25). However, the mechanism through which takinib elicits its anti-inflammatory activity remains elusive. While this inhibitor shows great promise, a thorough analysis of its inhibitor function and its potential off-target effects is necessary before addressing its clinical potential or its use in inflammatory conditions. An analysis through Western blot showed an unexpected increase in IL-1β-induced TAK1 phosphorylation—a prerequisite for and indicator of its functional potential—by takinib while simultaneously demonstrating the inhibition of the JAK/STAT pathway in human rheumatoid arthritis synovial fibroblasts (RASFs) in vitro. In THP-1 monocyte-derived macrophages, takinib again led to the lipopolysaccharide-induced phosphorylation of TAK1 without a marked inhibition of the TAK1 downstream effectors, namely, of c-Jun N-terminal kinase (JNK), phospho-c-Jun, NF-κB phospho-p65 or phospho-IκBα. Taken together, these findings indicate that takinib inhibits inflammation in these cells by targeting multiple signaling pathways, most notably the JAK/STAT pathway in human RASFs. MDPI 2021-11-22 /pmc/articles/PMC8621335/ /pubmed/34830460 http://dx.doi.org/10.3390/ijms222212580 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Panipinto, Paul M.
Singh, Anil K.
Shaikh, Farheen S.
Siegel, Ruby J.
Chourasia, Mukesh
Ahmed, Salahuddin
Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
title Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
title_full Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
title_fullStr Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
title_full_unstemmed Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
title_short Takinib Inhibits Inflammation in Human Rheumatoid Arthritis Synovial Fibroblasts by Targeting the Janus Kinase-Signal Transducer and Activator of Transcription 3 (JAK/STAT3) Pathway
title_sort takinib inhibits inflammation in human rheumatoid arthritis synovial fibroblasts by targeting the janus kinase-signal transducer and activator of transcription 3 (jak/stat3) pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621335/
https://www.ncbi.nlm.nih.gov/pubmed/34830460
http://dx.doi.org/10.3390/ijms222212580
work_keys_str_mv AT panipintopaulm takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway
AT singhanilk takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway
AT shaikhfarheens takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway
AT siegelrubyj takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway
AT chourasiamukesh takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway
AT ahmedsalahuddin takinibinhibitsinflammationinhumanrheumatoidarthritissynovialfibroblastsbytargetingthejanuskinasesignaltransducerandactivatoroftranscription3jakstat3pathway